| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab5cc770608c61eaa2ea32f45d2afd53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87343f0391f5074a8ffb73f681e41648 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K4-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate |
2012-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfdece373fc372b5b8e3bfcda9006b25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_360d44285a684ca9b88dbfb6754ced3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d490a9718d272cea56df07207aca460
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9412ca7c3903e5fa6421e9af1dec6102 |
| publicationDate |
2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2832521-A1 |
| titleOfInvention |
Therapeutic peptides and use thereof against huntington's disease |
| abstract |
The present invention relates to novel therapeutic compounds against Huntington's chorea. More particularly, the invention relates to an isolated peptide having a size of less than 100 amino acids and comprising: a first sequence having at least 80% identity with the AASSG sequence (SEQ ID No. 1), or a second sequence having at least 80% identity with the sequence XAGXDXXTEXPXS (SEQ ID NO: 2), wherein X is any amino acid. The present invention also relates to the use of an isolated peptide having a size less than 200 amino acids and having the sequence or sequences defined above, as a drug. |
| priorityDate |
2011-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |